Caloric restriction may affect different cell types in different ways as seen with intestinal stem cells that get prodded by neighboring Paneth cells to proliferate under calorie restriction conditions rather than responding with their own signaling program.
In Brief
Caloric restriction may affect different cell types in different ways as seen with intestinal stem cells that get prodded by neighboring Paneth cells to proliferate under calorie restriction conditions rather than responding with their own signaling program.
INTRODUCTION
The intestine is made up of finger-like structures termed villi, which contain the differentiated epithelial, endocrine, and goblet cells. Structures at the base of villi termed crypts contain the intestinal stem cells (ISCs) and Paneth cells, the latter of which serve as niche cells for ISCs. Although no single marker encompassing the entire ISC pool has been identified, Lgr5 + cells constitute the majority of ISCs under normal conditions (Barker et al., 2007 (Barker et al., , 2013 . The homeostasis of the intestinal epithelium is maintained by a delicate balance between the self-renewal and differentiation of ISCs (Simons and Clevers, 2011) to highly proliferative progenitors called transit-amplifying (TA) cells, which migrate from the crypt to the villus and give rise to the differentiated cells, including the absorptive enterocytes (Barker, 2014) . Paneth cells, which reside in close association with the LGR5 + ISCs near the base of crypt, are an important source of essential niche signals for ISC maintenance, including EGF, TGF-a, Wnt3, and the Notch ligand Dll4 (Sato et al., 2011) . The Paneth cells can also respond to calorie restriction (CR), by downregulating the mammalian target of rapamycin complex 1 (mTORC1) to induce the bone stromal antigen 1 (Bst-1), an ectoenzyme that produces the paracrine factor cyclic ADP ribose (cADPR) (Yilmaz et al., 2012) . The secreted cADPR mediates an increase in self-renewal and expansion of the ISC pool (Yilmaz et al., 2012) . mTORC1 kinase phosphorylates p70 ribosomal S6 kinase (S6K1), which helps drive protein synthesis, cell growth, and metabolism by phosphorylating ribosomal protein S6 (Magnuson et al., 2012) . The mTOR inhibitor rapamycin has been reported to inhibit carcinogenesis and increase the lifespan in APC (multiple intestinal neoplasia [Min]/+) mice, which develop tumors after loss of heterozygosity of APC (Faller et al., 2015; Hasty et al., 2014) . Consistent with this finding, the mTORC1-S6K1 axis was shown to drive the proliferation of APC-deficient enterocytes (Faller et al., 2015) . S6K1 is activated by the phosphorylation of multiple serine and threonine residues in a stepwise manner by mTORC1 and phosphoinositide-dependent kinase 1 (PDK1) in response to stimulation by a variety of nutrients, growth factors, and cytokines (Burnett et al., 1998; Dennis et al., 1998; Pullen et al., 1998) . In addition to phosphorylation, S6K1 is also regulated by lysine acetylation (Fenton et al., 2010a (Fenton et al., , 2010b Hong et al., 2014) . Importantly, acetylation of the C-terminal region of S6K1 has been reported to inhibit phosphorylation of S6K1 by mTORC1 (Hong et al., 2014) .
SIRT1 is the mammalian homolog of yeast Sir2 and both are NAD-dependent protein deacetylases (Imai et al., 2000) . SIRT1 is involved in a wide range of cellular processes including aging, stress response, metabolism, cell proliferation, and apoptosis (Finkel et al., 2009; Guarente, 2013) . SIRT1 also mediates many of the beneficial metabolic effects of CR and its activity plays an important role in the maintenance of health. SIRT1 has been shown to deacetylate the C terminus of S6K1 to relieve inhibition of phosphorylation by mTORC1 (Hong et al., 2014) . This activity portends that, at least in certain settings, SIRT1 could potentiate cell division via the mTORC1-S6K1 axis.
Here, we show the opposite responses to diet of mTORC1 in ISCs compared to Paneth cells. The mTORC1-S6K1 axis is absolutely required and upregulated in ISCs for their expansion in CR. Paneth cell signaling activates SIRT1, which deacetylates S6K1 to promote its phosphorylation by mTORC1, resulting in an increase in protein synthesis and expansion of cell number. Previous models based on the importance of mTORC1 inhibition in Paneth cell signaling predicted that rapamycin treatment of mice would mimic CR in triggering ISC expansion in ad libitum fed mice. However, our new findings suggested that rapamycin Wild-type (WT) and villin-cre intestine specific SIRT1 KO (VilKO) mice (3 months old) were subjected to long-term (more than 25 weeks) calorie restriction (CR). (A) H&E staining images and the quantification of the crypt size and villus size in the intestine of wild-type ad libitum fed (WT-AD), wild-type calorie restricted (WT-CR), VilKO-AD, and VilKO-CR (six mice per group, 100 crypt/villus units per mouse). All histological images in this and subsequent figures are typical of numerous tissue samples analyzed. Original magnifications: 1003.
would block the effects of CR on ISCs, which is what we observed. Thus, our findings detail a pathway by which niche cells and stem cells communicate in response to diet and reveal the complexity of designing pharmacological interventions to elicit effects of CR on an entire organ system.
RESULTS

Intestinal SIRT1 Is Required for the Effects of Calorie Restriction
To assess the involvement of SIRT1 in the ISC response to CR, we generated intestine-specific SIRT1 knockout (VilKO) mice, by crossing mice expressing the cre recombinase under the control of Villin promoter (Madison et al., 2002) , which is expressed in all gut cells ( Figure S1A ) to mice carrying the floxed SIRT1 allele (Cheng et al., 2003) . The loxP sites flank exon 4 of the SIRT1 gene, which corresponds to the catalytic domain of the enzyme. VilKO mice are homozygous for the SIRT1 floxed allele, carry one copy of Villin-cre, and generate a smaller SIRT1 protein that lacks enzymatic activity ( Figure S1B ). SIRT1 was shown to be deleted in whole gut ( Figure S1B ) and isolated intestinal stem cells (ISCs) (Figures S1C and S1D) in VilKO mice. All wildtype (WT) and VilKO mice and other mice used in this study are in the C57BL/6 background.
WT and VilKO mice were subjected to long-term CR (more than 25 weeks at a 70% ad libitum [AD] food intake). CR resulted in a substantial loss in body weight and intestine mass in WT and VilKO mice compared with AD fed counterparts (Figures S1E and S1F) . Consistent with the previous report (Yilmaz et al., 2012) , long-term CR induced the expansion of crypts (47.5% increase) and shrinkage of villi (13.5% reduction) in WT mice ( Figure 1A ). This expansion in the ISC compartment may help preserve the stem cell pool as a part of the longevity response to CR, while the villi contraction may be related to the reduced need for food adsorption during CR. Importantly, both effects were abolished in VilKO mice ( Figure 1A ). In proportion with villi downsizing, CR reduced the frequency of chromogranin A + enteroendocrine cells, goblet cells, and absorptive enterocytes in WT mice but not in VilKO mice (Figures S1G-S1I). Metabolic characterization of VilKO-CR mice revealed mild glucose intolerance compared with WT-CR mice in oral glucose tolerance tests (OGTT), but not in intraperitoneal glucose tolerance test (IPGTT) ( Figure S1J ).
Next, to investigate how CR influenced the frequency of proliferative cells in WT versus VilKO mice, we performed short-term (2 hr) bromodeoxyuridine (BrdU) labeling, which marks ISCs and TA cells in crypts (Figures 1B and S1K) . As for the incorporation of BrdU into total crypt cells (ISCs and TA cells), there was no difference between AD and CR fed mice ( Figure S1K ). On the other hand, BrdU incorporation into the crypt base columnar (CBC) cells, which are stem cells wedged between Paneth cells (Barker et al., 2012) , indicated that replicating ISCs increased by 74.3% in CR compared to AD fed WT mice. However, BrdU incorporation into CBC cells did not increase in VilKO mice ( Figure 1B ). To investigate more specifically how CR influenced the frequency of ISCs in WT versus VilKO mice, we performed in situ hybridization (ISH) for Olfactomedin-4 (Olfm4), which is a marker of LGR5 + ISCs (van der Flier et al., 2009a (van der Flier et al., , 2009b . Whereas the number of Olfm4
+ -positive cells in the crypts of WT-CR mice increased by 77.4% compared with AD fed counterparts, the number in VilKO-CR mice did not increase ( Figure 1C ). Furthermore, we crossed mice carrying the floxed SIRT1 allele to Lgr5-EGFP-IRES-CreERT2 mice (Barker et al., 2007) , which express EGFP under control of the ISC-specific LGR5 promoter. ISCs-specific SIRT1 deletion (Figures S1L and S1M) by tamoxifen administration also abrogated the response to CR in these mice (Figure S1N) . These results all indicate that SIRT1 is required for the increased self-renewal and expansion of ISCs in CR and the consequent reduction in the differentiated cells comprising the villi.
SIRT1 Overexpression Mimics the Effect of CR In Vivo
The above experiments showed gut SIRT1 is required for the observed responses to CR. To investigate whether SIRT1 activation was sufficient for these responses, we tested the effect of SIRT1 overexpression in the intestine using the Sir2d mice, which overexpress SIRT1 in numerous tissues (Bordone et al., 2007) . We confirmed that SIRT1 is overexpressed in the intestine of Sir2d mice by immunohistochemistry ( Figure S2A ). Interestingly, similar to long-term WT-CR mice, Sir2d mice fed AD showed an expansion of crypt size (34.4% increase) and shrinkage of villi (13.6% reduction) ( Figure 2A ).
Consistent with this expansion, the incorporation of BrdU into the CBC cells in AD fed Sir2d mice increased by 73.2% compared with WT mice ( Figure 2B ). Sir2d-crypts from AD fed mice showed a 49.6% increase in Olfm4 + -positive cells compared to WT mice ( Figure 2C ). Olfm4 + -positive ISCs in Sir2d mice subjected to CR did not show any additional response to CR, suggesting that SIRT1 gain of function and CR activation of ISCs are in the same pathway ( Figure S2B ). In summary, SIRT1 overexpression in AD mice mimics the effect of CR on ISC homeostasis in vivo, which provides additional support that SIRT1 is required in the gut for the response to CR and suggests that its activation is sufficient.
The Formation of Intestinal Crypt Organoids Ex Vivo Is Regulated by SIRT1
To further investigate the effects of SIRT1 on the proliferation of ISCs, we isolated crypts from WT (AD or CR) and VilKO (AD or CR) mice and maintained them in culture on Matrigel in the media, as described previously (Sato et al., 2009; Sato and Clevers, 2013 Figure S1 and Table S1 .
organoids that are initiated by ISCs and also contain differentiated intestinal cells arising during growth of the colony. Thus, this assay counts functional ISCs ex vivo. Consistent with the previous report (Yilmaz et al., 2012) , crypts from WT-CR mice formed 1.8-fold more organoid colonies on day 5 than those from WT-AD mice ( Figure 3A) . As with the mice in Figure 1 , the effect of CR to increase organoid colonies was abolished in crypts isolated from VilKO-CR mice ( Figure 3A) . (C) ISCs and Paneth cells were isolated from AD and CR mice by flow cytometry to about 96% purity and 2 3 10 3 cells each were co-cultured (detailed in Figure S3A ). The number of colonies was assessed at day 6 (n = 3). See also Figure S3 and Table S1 .
Next, we isolated crypts from Sir2d mice and cultured them. Crypts from Sir2d mice formed 1.8-fold more organoids than those from WT mice ( Figure 3B ) These data indicate that the crypt culture model mirrors the in vivo effects on ISCs of SIRT1 loss or gain of function in the gut . Figure S3A ). First, we assessed the purity of isolated Lgr5-EGFP hi ISCs by fluorescence of EGFP and found that >95% of isolated cells were EGFP hi -positive ( Figure S3A ). We also confirmed these cells were not stained by antibodies against the Paneth cells marker lysozyme (data not shown). We next assessed the purity of Paneth cells isolated by immunostaining of lysozyme (Roth et al., 2012; Yilmaz et al., 2012) and found that again >95% of the isolated cells were lysozyme-positive ( Figure S3A ).
SIRT1 in ISCs but
We cocultivated 2 3 10 3 Paneth cells and 2 3 10 3 ISCs, isolated from AD and CR mice, and assayed organoid colony formation at day 6 with or without induction of b-catenin using the glycogen synthase kinase 3b (GSK3b) inhibitor CHIR99021(CHIR), which is known to stimulate organoid formation (Yin et al., 2014 ) (Figures 3C, no induction, and S3B, with induction). We first confirmed that cultured ISCs form organoid colonies with lumenal structures on day 6 as described previously (Figures S3B and S3D) (Sato et al., 2009 ). Addition of CHIR promoted colony formation from Lgr5-EGFP hi ISCs by 20-fold under all conditions tested, but its presence did not alter any of the effects we describe below.
Consistent with the prior study (Yilmaz et al., 2012) , Paneth cells from CR mice (CR-Paneth cells) significantly promoted colony formation when mixed with ISCs compared to Paneth cells from AD mice and this was observed with or without CHIR ( Figures 3C and S3B ). Interestingly, CR-ISCs formed significantly more colonies compared to AD-ISCs when mixed with AD-Paneth cells (Figures 3C and S3B) , which is not consistent with the previous study (Yilmaz et al., 2012) . We hypothesized this difference may be derived from the difference in the method of crypt isolation, in particular the higher EDTA concentration and longer time of isolation in the prior study. Indeed, CR-ISCs did not form more colonies compared to AD-ISCs when crypts were isolated with the longer time incubation and with higher concentration of EDTA (10 mM), as in the previous study ( Figure S3C ). In the following experiments, ISCs were isolated with the lower concentration of EDTA (2 mM) and shorter isolation times (Sato et al., 2009; Sato and Clevers, 2013) . Next, we isolated ISCs and Paneth cells from WT and Sir2d mice fed AD and co-cultured them. Sir2d-ISCs formed 1.7-fold more colonies compared to WT ISCs from AD mice in the presence or absence of WT Paneth cells ( Figures 3D and S3D) . Importantly, Sir2d-ISCs did not form more colonies when mixed with CRPaneth cells, suggesting again that SIRT1 activation in ISCs and CR induction are in the same pathway ( Figure S3E ). In contrast, Sir2d-Paneth cells did not significantly increase colony formation compared with WT-Paneth cells when mixed with WT-ISCs ( Figures 3E and S3F ).
These results suggested that SIRT1 in ISCs, but not in Paneth cells, plays an important role in the response to CR. To confirm this conclusion, we co-cultured ISCs from mice homozygous for the SIRT1 floxed allele and heterozygous for Lgr5-EGFP-IRES-CreERT2 with AD or CR-Paneth cells in the presence of 4-hydroxytamoxifen, which knocks out SIRT1 in the EGFP-positive ISCs. Again, ISCs in which SIRT1 was deleted (LgR5KO-ISCs), did not respond to CR-Paneth cells (Figures 3F and S3G) , demonstrating an essential role of SIRT1 in ISCs in this response. Furthermore, Paneth cells from VilKO CR mice promoted colony formation to the same degree as those from wild-type CR mice, indicating that Paneth cells in which SIRT1 is deleted generated the ISC stimulatory signal in response to CR ( Figure 3G ). In summary, these results suggest that SIRT1 in ISCs, and not in Paneth cells, is necessary and sufficient to mediate the effects of CR on ISC self-renewal and expansion.
cADPR, which is the signal sent from Paneth cells to ISCs during CR, can also stimulate organoid body formation in isolated crypts (Yilmaz et al., 2012) . We thus treated ISCs from WT-AD mice with cADPR and observed an increase in organoid bodies. SIRT1 depletion in ISCs abolished the increased efficiency of organoid formation promoted by cADPR ( Figure S3H ). We next treated crypts from WT mice with nicotinamide mononucleotide (NMN), a NAD + precursor, which increases intracellular NAD + levels and hyperactivates SIRT1 (Yoshino et al., 2011) . This regimen also increased organoid body formation, and the increase was again abolished by SIRT1 depletion ( Figure S3I ). These findings, along with the in vivo studies above, suggest that SIRT1 activation in ISCs is necessary and sufficient for ISCs to show the phenotypes of CR. . This finding also explains why high EDTA during crypt isolation extinguishes the activation of ISCs by CR, as discussed above. Oppositely, the treatment of ISCs with calcium ionophore, ionomycin, significantly promoted colony formation ( Figure S4A ). Because SIRT1 has been reported to be activated by Ca 2+ via calmodulin-dependent protein kinase kinase beta (CaMKK beta), in certain cells types (Wen et al., 2013; Iwabu et al., 2010) , we treated AD-ISCs with a specific CaMKK inhibitor STO609 and co-cultured these cells with AD or CR-Paneth cells. STO609 treatment of ISCs completely abolished the effect of CR Paneth cells ( Figure 4C ). Further, phosphorylation of CAMKK in crypts was increased by CR ( Figure S4B ). Importantly, STO609 treatment of Sir2d-ISCs and CR-ISCs did not affect their colony formation efficiency ( Figures 4D and S4C ), suggesting that SIRT1 works downstream of CaMKK in the ISC response pathway and providing increased confidence for the specificity of the drug.
AMPK-Nampt-SIRT1 Loop in ISCs Regulates the Proliferation of ISCs in CR
CaMKK has been reported to activate SIRT1 through two different pathways. One is by SIRT1 phosphorylation (Wen et al., 2013 ) and the other is by phosphorylating and activating its known substrate, AMP-activated protein kinase (AMPK) (Iwabu et al., 2010) , which we detail below. First, we assessed SIRT1 phosphorylation (Ser47) by immunoblotting of total crypt lysate from AD and CR mice by anti-phospho-SIRT1 (Ser47) antibodies. The level of SIRT1 phosphorylation did not increase significantly in CR ( Figure S4D ). Instead, we observed that phosphorylation of AMPK was increased in CR-crypts and CR-ISCs of wild-type mice ( Figures 4E and 4F) . Further, AD-crypts treated with cADPR or ionomycin showed upregulation of AMPK phosphorylation, which was abolished by STO609 pretreatment ( Figure S4E ). ADcrypts of Sir2d mice also showed increased AMPK phosphorylation ( Figure 4E ), likely due to the known the activation of the other known AMPK kinase, LKB1, by SIRT1-mediated deacetylation (Hou et al., 2008; Lan et al., 2008) . Indeed, the upregulation of LKB1 phosphorylation was also observed in CR-crypts, which have higher SIRT1 activity (see below) ( Figure S4F ). We next treated AD-ISCs by a specific AMPK inhibitor Compound C and co-cultured with AD or CR-Paneth cells. Compound C treatment of ISCs abrogated their colony formation increase in response to CR Paneth cells, indicating AMPK activation is necessary for this effect ( Figure 4G ). Compound C treatment also suppressed the high colony forming potential of CR-ISCs ( Figure S4H ), implying that AMPK is necessary for the maintenance of the activated status of CR-ISCs. However, Compound C treatment of Sir2d-ISCs did not affect their elevated colony formation efficiency, suggesting that the gain of function SIRT1 mutation bypassed the need for AMPK activity ( Figure S4G ).
AMPK is known to activate SIRT1 deacetylase activity via an increase of NAD + levels due to stimulation of transcription of the gene encoding the NAD-synthesis enzyme, nicotinamide phosphoribosyl transferase or Nampt (Brandauer et al., 2013; Cantó et al., 2009 ). Thus, SIRT1 and AMPK comprise a mutually enforcing activation loop. In line with this mechanism, we found that addition of the AMPK activator 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) to AD-ISCs promoted colony formation of ISCs ( Figures 4H and S4I) . Moreover, by quantitative real-time PCR, we found that the level of Nampt mRNA in crypts and ISCs was increased by CR, whereas the level of mRNA of SIRT1 and the NAD consuming enzymes PARP1 and PARP2 did not change ( Figures 4I and S4J ). Brief treatment of CR-crypts with Compound C significantly reduced this upregulation of Nampt mRNA, suggesting that AMPK is necessary for the elevation of Nampt expression in CR ( Figure S4K ). The above experiments all indicate that activation of the AMPK/Nampt/SIRT1 loop in ISCs plays a central role in the response to cADPR released from Paneth cells in CR.
SIRT1 Activates S6K1 Thr389 Phosphorylation in ISCs during CR
We next investigated what might be downstream of SIRT1 in driving ISC renewal by CR-Paneth cells. We first checked the PI3K/AKT pathway, which mediates many effects of growth factors (Hers et al., 2011) , and found that it was not induced by CR nor required for the induction of ISCs by CR-Paneth cells (Figures S5A and S5B ). Because the APC/b-catenin pathway can induce ISC growth (Fevr et al., 2007; Sato et al., 2011; Yin et al., 2014 ; also see above), we immunostained b-catenin and measured RNAs of three of its target genes in CR-crypts and found no induction ( Figures S5C and S5D) . We thus checked the mTORC1/S6K axis, which promotes protein synthesis and cell growth in many contexts (Magnuson et al., 2012) . We assessed markers of S6K1 activation such as S6K1 Thr389 phosphorylation (mTORC1-dependent), S6K1 Thr424/ Ser421 phosphorylation (mTORC1-independent), as well as phosphorylation of S6 (a S6K1 substrate) in crypt and ISC lysates from AD and CR mice. S6K1 Thr389 phosphorylation and S6 phosphorylation were significantly induced in CR-crypts and CR-ISCs, but S6K1 Thr424/Ser421 phosphorylation was not ( Figures 5A and  5B) . Surprisingly, the phosphorylation of another mTORC1 substrate 4EBP1 was not induced in CR-crypts and CR-ISCs, suggesting the mTORC1/S6K axis is activated for a specific substrate ( Figures 5B and S6A ). We could not detect the induction of S6K1 phosphorylation in crypts isolated in the high EDTA (10 mM) conditions of Yilmaz et al. (2012) (Figure S6B ), likely because the Ca 2+ signaling in ISCs was extinguished, as by EGTA ( Figure 4B ). Activated mTORC1-S6K1 signaling resulted in the promotion of protein synthesis in CR-crypts and CR-ISCs, as shown by puromycin uptake (Schmidt et al., 2009) (Figures S6C and S6D ). Co-staining of puromycin and phosphorylated S6 showed a strong cell-to-cell correlation between the level of S6 phosphorylation and the level of protein synthesis ( Figure S6E ), suggesting mTORC1/S6K activity drives protein synthesis and ISC proliferation.
Immunohistochemistry also illustrated that S6 phosphorylation was greatly reduced in villi of CR mice as expected, but induced in crypts of these same mice ( Figures 5C and S6F ). The magnification of immunostained crypts confirmed S6 phosphorylation is upregulated by CR in ISCs and TA cells but not in Paneth cells ( Figure S6F ). The induction of S6K1 Thr389 phosphorylation and S6 phosphorylation by CR was completely abolished in VilKO crypts ( Figures 5C, 5D , and S6F). Moreover, ISC-specific SIRT1 deletion ( Figures S1L-S1N ) abrogated the induction of S6 phosphorylation by CR ( Figure 5E ), confirming that SIRT1 is required for the activation of mTORC1-S6K1 signaling by CR in ISCs. This conclusion was further supported by the induction of S6K1 and S6 phosphorylation without CR in AMPKactivated crypts and Sir2d-ISCs (Figures S6G-S6I) .
Because S6K1 Thr389 phosphorylation is reported to be upregulated via deacetylation by SIRT1 (Hong et al., 2014) , we assessed the acetylation status of S6K1 in crypts of CR or Sir2d mice. The acetylation of S6K1 was significantly reduced in CRversus AD-crypts as well as in crypts from Sir2d mice versus wild-type mice ( Figure 5F ). Moreover, S6K1 was highly acetylated in CR-crypts from VilKO mice ( Figure 5F ). These data suggest that SIRT1 deacetylates S6K1 in ISCs during CR to facilitate Thr389 phosphorylation by mTORC1 and S6 phosphorylation by S6K1 resulting in ISC expansion. Three lysines (484, 485, and 493) in the C-terminal region of S6K1 are reported to be acetylated by SIRT1 (Hong et al., 2014) . To investigate the direct role of S6K1 acetylation in the regulation of ISCs expansion, 
(legend continued on next page)
we transfected HA-tagged acetylation-defective (TKR) or acetylation-mimetic (TKQ) S6K1 mutants (Hong et al., 2014) , into WTISCs. We confirmed more than 50% of ISCs were successfully transfected by staining cells for HA (data not shown). The transfection of the TKR S6K1 mutant showed higher colony formation when co-cultured with AD-Paneth cells ( Figure 5G ), consistent with a gain of function activity. In contrast, the transfection of TKQ S6K1 mutant reduced the response to CR-Paneth cells ( Figure 5G ), consistent with a dominant inhibitory effect. These data lend further support to the notion that S6K1acetylation by SIRT1 regulates ISC expansion.
Inactivation of mTORC1 or S6K1 Suppresses the Increase of Colony Formation in CR Mice and Sir2d Mice
To address in more functional detail the role of the mTORC1/ S6K1 pathway in the proliferation of ISCs in CR, purified ISCs were treated with PF4708671, a specific S6K1 inhibitor (Pearce et al., 2010) , or the mTOR inhibitor, rapamycin, and then cocultured with AD and CR-Paneth cells. PF4708671 or rapamycin treatment of ISCs abolished the increase of the organoid formation by CR-Paneth cells ( Figures 6A and 6B ). Furthermore, PF4708671 or rapamycin treatment prevented the increase of the organoid formation in ISCs from Sir2d mice ( Figures 6C  and 6D ), providing further evidence that mTORC1/S6K1 signaling is downstream of SIRT1 in the ISC response to CRPaneth cells. Additional evidence for the order of this pathway is that S6K1 inhibition also suppressed the induction of organoids by AICAR or nicotinamide riboside (NR), another natural NAD + precursor (Cantó et al., 2012) (Figures 6E and 6F ).
Rapamycin Treatment Suppresses the Expansion of ISCs by CR In Vivo
To test whether S6K1-Thr389 phosphorylation is important for the expansion of the ISC pool in vivo, two separate studies were carried out in which AD or CR mice were treated with daily oral gavage of rapamycin (5 mg/kg body weight) (Figure 7 ) or an enterically released formulation of rapamycin (eRapa) (Harrison et al., 2009 ) at 14 mg/kg food for 2 months ( Figure S7 ). We confirmed that both rapamycin treatments greatly downregulated mTORC1 signaling in both villi (AD mice) and crypts (CR mice) ( Figures 7A,  S7A , and S7B). Chronic rapamycin treatment can suppress the assembly of mTOR and raptor (mTORC1) and also the assembly of mTOR and rictor (mTORC2) (Sarbassov et al., 2006) . However, we found that the assembly of the mTORC2 complex was not inhibited by rapamycin treatment ( Figure S7B ), but that of mTORC1 was. Thus, effects of rapamycin described below can be attributed to mTORC1 inhibition. Interestingly, our data also show that the assembly of mTORC1 and the phosphorylation of TSC2 or raptor were not affected by CR ( Figures S7B and S7C ), as might have been expected (Gwinn et al., 2008) , even though phosphorylation of AMPK was induced (see Discussion). Next to investigate how rapamycin treatment influenced the frequency of ISCs in AD and CR mice, BrdU labeling and in situ hybridization for the ISC marker Olfm4 were performed. Rapamycin treatment did not alter the population of ISCs in AD mice ( Figures 7C and S7E) . However, rapamycin treatment did significantly suppress uptake of BrdU into CBC cells ( Figures  7B and S7D ) and the expansion of Olfm4 + -positive cells during CR ( Figures 7C and S7E) . Consistent with the Olfm4 results (Figure 7C) , rapamycin treatment also suppressed the expansion of LgR5-GFP-positive cells during CR (Figures S7F and S7G) . Finally, we carried out one additional long-term CR study in which mice were subjected to 6 months CR along with oral gavage of rapamycin or saline. The expansion of crypts and shrinkage of villi induced by long-term CR were again abrogated by rapamycin treatment ( Figure 7D ). The above data demonstrate in vivo that the mTORC/S6K1 axis is required to mediate the ISC expansion and villi contraction in CR mice.
CR was previously reported to increase the number of LgR5-positive ISCs (Yilmaz et al., 2012) . In that study, Lgr5-GFP cells were counted by FACS analysis of cells disaggregated from crypts, whereas we performed in situ GFP-or Olfm4-staining in the gut to detect ISCs. Variegated expression of the Lgr5-EGFP-IRES-CreERT2 transgene in the small intestine has been reported (Barker et al., 2007) , and indeed we found only 50% of total crypts contained GFP-positive cells ( Figures S7H and  S7I) . Unexpectedly, we found rapamycin treatment increased the fraction of crypts that are GFP-positive ( Figures S7H and  S7I) , suggesting that the assessment of GFP-positive cells in the gut after disaggregation of cells from crypts can be misleading for assessing ISC expansion (number per crypt).
DISCUSSION
The mammalian intestine is an ideal organ for studying the interaction between adult stem cells (ISCs) and niche cells (Paneth cells), because of the precise geometric location of both cell types near the bottom of the crypts, which are structures at the base of gut villi. Several signals emitted from Paneth cells maintain ISCs including cADPR, which is synthesized from NAD by Paneth cells during calorie restriction (CR) and promotes expansion of the ISC population in crypts and contraction of the differentiated cells of the villus (Sato et al., 2011; Yilmaz et al., 2012) . Here, we trace the signaling pathway in ISCs and show that ISCs respond to cADPR via first, Ca 2+ signaling, second, SIRT1/AMPK activation and NAD synthesis, and third, S6K1 (E) Crypt lysates isolated from AD and CR mice were immunoblotted with SIRT1, AMPK, phospho-AMPK, and GAPDH antibodies. The images are representative of at least three independent experiments. (F) ISC lysates isolated from AD and CR mice were immunoblotted with AMPK and phospho-AMPK. The images are representative of two independent experiments. (G) AD-ISCs were treated or not with 10 mM Compound C, a specific AMPK inhibitor, for 30 min at 37 C and were co-cultured with AD or CR-Paneth cells (n = 3).
(H) AD-ISCs were treated or not with 1 mM of the AMPK activator 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) for 30 min at 37 C and were cocultured with AD-Paneth cells (n = 4). (I) SIRT1, Nampt, PARP1, and PARP2 mRNA levels were determined by quantitative real-time PCR using ISCs isolated from AD and CR mice (n = 3). Values represent the mean ± SEM. Significant differences are denoted by p values (t test). See also Figure S4 and Table S1 . (legend continued on next page) deacetylation by SIRT1 and consequent activation by mTORC1 phosphorylation ( Figure 7E ). Consistent with this model, rapamycin dosing of mice inhibits mTORC1 and prevents the CR induction of ISC expansion, an effect opposite to reports that this drug may be a CR mimetic. Table S1 . (E) Isolated wild-type AD-crypts were treated or not with 1 mM AICAR and 10 mM PF4708671 as indicated for 30 min at 37 C and were cultured (n = 3).
(F) Isolated wild-type AD-crypts were treated or not with 10 mM PF4708671 for 30 min at 37 C and were cultured in medium with or without 1 mM NR as indicated (n = 3). Values represent the mean ± SEM. Significant differences are denoted by p values (t test). See also Table S1 .
Implications for Signaling in ISCs mTORC1 activity can be suppressed through the downregulation of PI3K-AKT signaling and AMPK activation in food deprivation and calorie restriction. Indeed, mTORC1 signaling is greatly suppressed in CR villi ( Figures 5C, 5D , and S6F). However, our data show that the PI3K-AKT pathway in crypts is not altered by CR ( Figure S5A ). Further, the phosphorylation of 4EBP1, another substrate of mTORC1, does not change in CRcrypts or CR-ISCs ( Figures 5B and S6A ). The selective increase in phosphorylation of S6K1 over 4EBP1 can be explained by the deacetylation of S6K1 by SIRT1, which renders it a better substrate for mTORC1 (Hong et al., 2014) . In addition, phosphorylation of TSC2 and raptor is not induced in CRcrypts even though phosphorylation of AMPK is ( Figure S7C) . Moreover, assembly of mTOR and raptor into mTORC1 is not inhibited in CR-crypts, but is inhibited by rapamycin ( Figure S7B ). 
(legend continued on next page)
ISCs thus appear to be insulated from the direct effects of CR and instead respond solely to the cADPR signal from Paneth cells, which themselves are entrained by nutrients (Yilmaz et al., 2012) . This unusual situation would allow intimate communication between adult stem cells and niche cells, in which the direct response to nutrients is mediated via the niche, and the effect on stem cells is mediated solely by niche signaling. Such a mechanism might allow unique outputs in the stem cells to effects of nutrient signaling in the niche, e.g., AMPK activation without AKT activation or mTORC1 suppression. Consistent with this idea, Yilmaz et al., (2012) showed that insulin activates mTORC1 in Paneth cells, but not in ISCs.
Implications for Self-Renewal versus Differentiation
Numerous studies demonstrate that the pool of adult stem cells declines with aging (Boyette and Tuan, 2014) . One possible reason for this decline is a decrease in self-renewal thereby depleting the stem cell pool. In this light, CR appears to favor self-renewal of ISCs at the expense of differentiation, because both an increase in ISCs and a decrease in differentiated cells are observed (Yilmaz et al., 2012) . These changes can be rationalized, because the expanded ISC pool may be a part of a larger program of extended lifespan in CR mice. How might our findings shed light on the ISC decision to favor self-renewal over differentiation? In general, SIRT1 and mTORC1 signaling are not active in the same cell because they are activated by opposite conditions; mTORC1 is activated by food abundance and SIRT1 is activated by food scarcity. However, two factors rescue any reduction in mTORC1 activity in ISCs of CR mice. First, the cADPR secreted by Paneth cells results in deacetylation of S6K1 by SIRT1 in ISCs, which renders it a better substrate for phosphorylation by mTORC1 (Hong et al., 2014) . Second, insulation of ISCs from direct nutrient effects may prevent a decline in mTORC1 activity due to disassembly of mTOR and raptor, as discussed above. We hypothesize that having simultaneous activities of both the mTORC1/S6K1 axis, and SIRT1 may favor the self-renewal and increase in the ISC pool in CR. More specifically, we suggest that mTORC1 helps drive cell division of ISCs, while SIRT1 promotes the decision for self-renewal as opposed to differentiation. In this regard, it is interesting to note that embryonic stem cells and IPS cells express extremely high levels of SIRT1 (Calvanese et al., 2010; De Bonis et al., 2014; Saunders et al., 2010 ) and this might enhance the self-renewal ability of these pluripotent cells.
Implications for Drug Development for Aging
Our findings suggest that developing drugs to treat aging by targeting key metabolic pathways will be a delicate enterprise. To wit, mTORC1 plays opposite roles in Paneth cells and ISCs in signaling stem cell expansion in CR. Its downregulation in Paneth cells is required to send the cADPR signal and its activity in ISCs is required to respond to the signal. Indeed, we found that the mTORC1 inhibitor rapamycin blocked the expansion of ISCs during CR in mice. Our findings do not rule out the possibility of finding a dose of the drug that would inhibit mTORC1 in Paneth cells to a level that promotes synthesis of cADPR, but still leave enough activity in ISCs to permit and expansion of the stem cell compartment. Alternatively, dietary supplementation with NAD precursors can compensate for NAD loss with aging and this has a salutary metabolic effect in mice (Imai and Guarente, 2014) . In the intestine, NAD precursors or SIRT1 activating compounds are predicted not to impair signaling from Paneth cells (and may even foster cADPR synthesis) and to activate SIRT1 in ISCs, which should increase the pool of ISCs. It will be interesting to test whether such interventions improve the maintenance of the adult stem cell pool in the aging gut. More generally, it will be interesting to determine whether the signaling pathways we describe for the maintenance of ISCs by niche cells apply in the maintenance of other adult stem cell pools.
EXPERIMENTAL PROCEDURES
Mice and Calorie Restriction All mice were maintained in the C57BL/6 background and were housed on a 12 hr:12 hr light:dark cycle at controlled temperature (25 ± 1 C). Mice at the age of 10 to 20 weeks were either fed ad libitum or subjected to a 30% calorie restricted diet for more than 6 weeks. All animal procedures were in accordance with the MIT Animal Care Committee. Detailed methods for this and other categories can be found in the Supplemental Experimental Procedures.
Rapamycin Treatment
Rapamycin (LC Laboratories) was administered by oral gavage daily at a concentration of 5 mg/kg for more than 8 weeks. Or mice were fed microencapsulated rapamycin (Rapamycin Holdings)-containing diets (eRapa) at the concentration of 14 mg/kg food (14 ppm) (Harrison et al., 2009 ) for more than 8 weeks.
Crypt Isolation and Culture Crypts were isolated described previously (Sato et al., 2009; Sato and Clevers, 2013) . Isolated crypts were collected in crypt culture medium, counted, embedded in Matrigel (Corning), and cultured in a crypt culture medium. The number of organoids was counted 5 days after plating.
Co-culture of Isolated ISCs and Paneth Cells ISC and Paneth cell isolation was performed as described previously (Roth et al., 2012; Yilmaz et al., 2012) . ISC (2,000 cells) and Paneth (2,000 cells) cells were then seeded into Matrigel and co-cultured. The number of colonies with lumen was quantitated at day 6 of culture. See also Figure S7 and Table S1 .
Immunocytochemistry Isolated ISCs were then fixed, permeabilized, blocked, and stained with primary antibodies. Cells were imaged on a Zeiss Axio Imager M1 fluorescent microscope. Quantitative comparison of signal intensity per cell area was performed by Image J software. At least four non-overlapping locations on each sample were selected to calculate the average signal density.
Immunohistochemistry
Pieces of the proximal jejunum (1-4 cm from pylorus) were fixed overnight in 10% neutral-buffered formalin at room temperature, embedded in paraffin, and sectioned. Sections were deparaffinized, subjected to antigen retrieval, and then incubated with the antibodies. Microscopic images were obtained by a Zeiss Axio Imager M1 fluorescent microscope.
In Situ Hybridization Digoxigenin (DIG)-labeled Olfm4 RNA probe was made using cDNA (IMAGE mouse cDNA clone 9055739) obtained from GE Healthcare as templates. To confirm the specificity of the probe, we generated both sense and antisense probe. Detailed methods are described previously (Gregorieff and Clevers, 2010) .
Quantification
Crypt length and villus length were measured from the bottom of the crypt to the crypt-villus junction and from the crypt-villus junction to the tip of the villus, respectively, by ImageJ software. Quantification in each mouse was performed from 50-150 crypt/villus units per mouse. BrdU-positive CBC cells were counted as BrdU-positive cells adjacent to Paneth cells visualized at the bottom of crypts. Quantification of BrdU-or Olfm4-positive cells in each mouse was performed from 40-60 intact, well-orientated crypts per mouse under Zeiss Axio imager M1 microscope. The number of mice analyzed is indicated in the figure legends (Figures 1, 2 , 7, S1, S2, and S7).
Immunoblotting
Proteins extracts from crypts or ISCs were denatured by the addition of SDS loading buffer, boiled, resolved by SDS-PAGE, and analyzed by immunoblotting. The band density of all blots was quantified by Image J software.
Immunoprecipitation
Lysed crypt lysates were incubated with anti-S6K1 antibody (Santa Cruz sc-230) for 2 hr and with protein A-Agarose beads (Santa Cruz) overnight with gentle rocking at 4 C. Immunoprecipitates were denatured in SDS sample buffer and further analyzed by immunoblotting.
RNA Analysis by Real-Time qPCR RNA from crypts or ISCs was extracted by RNeasy Mini Kit (QIAGEN). RT-PCR reactions were performed on a LightCycler 480 II (Roche) using iQ SYBR Green Supermix (Bio-Rad). 
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